TipRanks
Go Ultimate55% OFF

Top Page

LRNZ

TrueShares Technology, AI & Deep Learning ETF (LRNZ)

Rating:66Neutral
Price Target:$66.00â–²(12.49% Upside)

LRNZ, the TrueShares Technology, AI & Deep Learning ETF, earns a solid overall rating thanks to several strong, growth-focused holdings like MongoDB, Palo Alto Networks, Datadog, CrowdStrike, and Samsara, which benefit from robust financial performance, positive earnings sentiment, and strategic positioning in AI and security. These strengths are partly offset by weaker names such as Schrodinger and some holdings with ongoing profitability and valuation challenges, and the fund’s heavy focus on technology and AI-related companies means investors face concentrated sector risk if sentiment or fundamentals in this area weaken.

Positive Factors
Strong Year-to-Date PerformanceThe ETF has delivered strong gains so far this year, showing solid momentum in its strategy.
Leading Technology and AI HoldingsMany of the largest positions, such as cybersecurity, cloud, and AI-related companies, have shown strong performance and help drive the fund’s returns.
Focused Sector Mix in Growth AreasHeavy exposure to technology and health care concentrates the fund in sectors that are key beneficiaries of AI and deep learning trends.
Negative Factors
High Expense RatioThe fund’s fee is relatively high for an ETF, which can reduce the portion of returns that investors keep over time.
Recent Short-Term WeaknessThe ETF has seen weak performance over the past month, showing that it can be sensitive to short-term market swings.
Concentrated U.S. and Tech ExposureWith almost all assets in U.S. stocks and a heavy tilt toward technology, the fund is more exposed to downturns in the U.S. tech sector and lacks global diversification.

LRNZ vs. SPDR S&P 500 ETF (SPY)

AUM
41.10M
Region
North America
Expense Ratio
0.69%
Beta
1.54
Issuer
TrueShares
Inception Date
Feb 28, 2020
Dividend Yield
0.11%
Asset Class
Equity
Index Tracked
No Underlying Index

LRNZ Summary

LRNZ is the TrueShares Technology, AI & Deep Learning ETF, focused on companies using artificial intelligence, deep learning, and robotics rather than tracking a traditional index. It mainly holds U.S. technology and health care firms that rely heavily on data and software, such as well-known names like Cloudflare and CrowdStrike. Investors might consider LRNZ if they want growth potential from cutting-edge tech and a way to spread their money across many AI-related companies instead of picking just one stock. A key risk is that it is heavily concentrated in technology and can go up or down sharply with swings in that sector.

How much will it cost me?

This ETF has an expense ratio of 0.69%, which means you’ll pay about $6.90 per year for every $1,000 you invest. That’s higher than the average ETF because it’s actively managed and focused on a specialized area of technology, AI, and deep learning.

What would affect this ETF?

This ETF is heavily focused on U.S. technology and AI-related companies like Cloudflare, CrowdStrike, and Snowflake, so it could benefit from growing demand for cloud computing, cybersecurity, and AI tools, as well as supportive regulations and business investment in automation and data analytics. On the downside, it may be hurt by rising interest rates that pressure high-growth tech valuations, tighter rules around data and AI use, or an economic slowdown that reduces spending on advanced software and health care innovation.

LRNZ Top 10 Holdings

LRNZ is leaning hard into U.S. AI and cloud infrastructure, with cybersecurity and data platforms doing most of the heavy lifting. CrowdStrike, Palo Alto Networks, and Datadog have been rising, acting like the fund’s digital bodyguards and key performance engines. Natera and Guardant Health add a fast-growing health-tech twist, also contributing positively. On the softer side, Cloudflare and Snowflake have seen more mixed, recently lagging action, occasionally tugging on returns. Overall, it’s a tech-heavy, AI-first portfolio with meaningful exposure to data, security, and next-gen healthcare innovation.

LRNZ top ten holdings
NameCompany NameWeight %Market ValueMarket CapYearly GainOverall Rating
NTRANTRANatera8.00%$3.15M$59.72B90.48%73Outperform
CRWDCRWDCrowdStrike Holdings7.21%$2.84M$256.42B78.13%67Neutral
NETNETCloudflare6.63%$2.61M$99.95B4.69%61Neutral
GHGHGuardant Health5.59%$2.20M$23.99B83.54%61Neutral
SNOWSNOWSnowflake5.49%$2.16M$107.99B5.75%54Neutral
PANWPANWPalo Alto Networks5.09%$2.00M$299.56B59.70%73Outperform
SDGRSDGRSchrodinger5.03%$1.98M$2.03B24.48%44Neutral
IOTIOTSamsara4.84%$1.90M$24.64B4.31%69Neutral
MDBMDBMongoDB4.30%$1.69M$28.43B-8.17%75Outperform
DDOGDDOGDatadog4.02%$1.58M$84.48B32.73%69Neutral

LRNZ Technical Analysis

Technical Analysis SentimentNegative
Last Price58.67

Price Trends

50DMA64.70Negative
100DMA63.00Negative
200DMA54.48Positive

Market Momentum

MACD-1.08Positive
RSI36.20Neutral
STOCH29.24Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For LRNZ, the sentiment is Negative. The current price of 58.67 is below the 20-day moving average (MA) of 64.43, below the 50-day MA of 64.70, and above the 200-day MA of 54.48, indicating a neutral trend. The MACD of -1.08 indicates Positive momentum. The RSI at 36.20 is Neutral, neither overbought nor oversold. The STOCH value of 29.24 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for LRNZ.

LRNZ Peer Comparison

Comparison Results

LRNZ against its peer funds
NamePricePrice TargetAUMExpense RatioOverall Rating
LRNZLRNZ$58.67$66.00(12.49% Upside)$41.10M0.69%66Neutral
CCSOCCSO$24.54$31.38(27.85% Upside)$45.24M0.35%68Neutral
TMGNTMGN$23.76$31.89(34.23% Upside)$43.33M0.88%75Outperform
BUILBUIL$22.80$33.82(48.37% Upside)$43.07M0.65%68Neutral
ANTWANTW$20.39$37.04(81.64% Upside)$33.75M0.59%64Neutral
EPAIEPAI$24.46$34.17(39.72% Upside)$4.96M0.88%72Outperform

Performance Comparison

-20%0%20%40%60%LRNZCCSOTMGNBUILANTWEPAIDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
LRNZ and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
LRNZTrueShares Technology, AI & Deep Learning ETF58.678.1616.15%
CCSOCarbon Collective Climate Solutions U.S. Equity ETF24.54-0.06-0.25%
TMGNTappAlpha Cboe Magnificent 10 Growth & Daily Income ETF23.760.642.76%
BUILRebuild America ETF22.80-2.06-8.31%
ANTWAnthropic AI Lab Ecosystem ETF20.39-4.63-18.52%
EPAIHarbor AI Inflection Strategy ETF24.464.6923.75%
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.